NEW YORK (GenomeWeb News) - Biotage today reported a 37-percent increase in net sales for the second quarter.
Net sales for the three months ended June 30 increased to SEK 128.3 million ($17.96 million) from SEK 93.5 million year over year. The growth is the result of acquisitions made in 2005, Biotage said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.